Uses of TSYI-PA102 to improve osteoarthritis
Patent Information
- Authority / Receiving Office
- TW · TW
- Patent Type
- Patents
- Current Assignee / Owner
- SYI BIOTECH CO LTD
- Filing Date
- 2025-01-21
- Publication Date
- 2026-08-01
Smart Images

Figure TWG2TB001903773_001 
Figure TWG2TB001903773_002 
Figure TWG2TB001903773_003
Abstract
Claims
1. Use of Cordyceps militaris TSYI-PA102 in the preparation of a composition for improving arthritis; wherein the composition is for oral administration.
2. The use as described in claim 1, wherein the Cordyceps militaris TSYI-PA102 is a deep-culture product.
3. The use as described in claim 1, wherein the arthritis is degenerative arthritis.
4. The use as described in claim 3, wherein the composition improves pain, inflammation, swelling, or loss of articular cartilage caused by osteoarthritis.
5. The use as described in claim 1, wherein the composition reduces the inflammatory indices IL-1β, IL-6 and TNF-α.
6. The use as described in claim 1, wherein the composition is a pharmaceutical composition, a nutritional supplement, or a health food.
7. The use as described in claim 1, wherein the composition comprises a pharmaceutically acceptable carrier, excipient, or diluent.
8. The use as described in claim 1, wherein the effective dose of TSYI-PA102 in the composition is 66 mg / kg body weight (mg / kg bw) or higher.
9. The use as described in claim 1, wherein the effective dose of TSYI-PA102 in the composition is 132 mg / kg body weight (mg / kg bw) or higher.
10. The use as described in claim 1, wherein the effective dose of TSYI-PA102 in the composition is 264 mg / kg body weight (mg / kg bw) or higher.